Cargando…
Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
BACKGROUND: The role of adjuvant chemotherapy in patients with pathological lymph node‐positive (pN+) resectable esophageal squamous cell carcinoma (ESCC) remains unclear. We aimed to explore whether adjuvant chemotherapy could improve the overall survival (OS) of patients with pN+ ESCC and whether...
Autores principales: | Fang, Shuogui, Zhong, Jian, Mai, Zihang, Li, Tong, Xie, Xiuying, Fu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972109/ https://www.ncbi.nlm.nih.gov/pubmed/36134648 http://dx.doi.org/10.1002/cam4.5264 |
Ejemplares similares
-
Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
por: Zhang, Liangze, et al.
Publicado: (2017) -
Adjuvant chemotherapy for lymph node positive esophageal squamous cell cancer: The prediction role of low mean platelet volume
por: Liu, Xiaoling, et al.
Publicado: (2022) -
Integration of Tumor Heterogeneity for Recurrence Prediction in Patients with Esophageal Squamous Cell Cancer
por: Mai, Zihang, et al.
Publicado: (2021) -
Comparisons of histological features among primary oral squamous cell carcinomas before and after adjuvant chemotherapy and their lymph node metastatic cancer lesions after adjuvant chemotherapy
por: Cheng, Feng-Chou, et al.
Publicado: (2022) -
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma
por: Jeon, Yeong Jeong, et al.
Publicado: (2023)